FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch
1. FDA approved Dexcom G7 15-Day CGM system for diabetes management. 2. Dexcom G7 has an 8.0% MARD, improving glucose monitoring accuracy. 3. Features include 15.5 days of wear, waterproof design, and Apple Watch integration. 4. Launch expected in the U.S. during the second half of 2025. 5. Price rise of 0.22% observed, reaching $66.99 as of Thursday.